Skip to main content
SpringerLink
Log in

Natural history and clinical features of aspirin-exacerbated respiratory disease

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinosinusitis, nasal polyposis, asthma and precipitation of asthma, and rhinitis attacks after ingestion of aspirin (ASA) and most other nonsteroidal antiinflammatory drugs (NSAIDs). Although precipitation of asthma attacks by ingestion of ASA and other NSAIDs is considered a hallmark of the syndrome, the respiratory mucosal inflammatory disease process begins and continues in the absence of ongoing or even intermittent exposure to ASA or NSAIDs. The typical patient with AERD is an adult who develops refractory chronic rhinitis in the third or fourth decade of life. The chronic rhinitis evolves into chronic eosinophilic rhinosinusitis with associated nasal polyposis. Anosmia appears in most patients. CT of the sinuses most often demonstrates pansinusitis and patients often undergo multiple sinus operations resulting in only limited temporary benefit. During the evolution of the sinus disease persistent asthma develops. Finally, if patients are exposed to ASA or NSAIDs acute respiratory reactions begin to occur. Despite subsequent avoidance of ASA and other NSAIDs, the respiratory mucosal inflammatory disease persists, often requiring systemic corticosteroids for control of both upper- and lower-respiratory tract symptoms. Adequate control of asthma can often only be accomplished with the simultaneous control of the associated rhinosinusitis. With few exceptions, once AERD develops it remains for the remainder of the patient’s life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stevenson, D., and Simon, R. A. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs, in Allergy: Principles and Practice, Middleton, Jr., E., Ellis, E. F. Yunginger, J. W., Reed, C. E., Adkinson, N. F., Jr., and Busse, W. W., eds., vol. 2, 5th ed. Mosby, St. Louis, 1998, pp. 1225–1234.

    Google Scholar 

  2. Stevenson, D. D. (2001), Anaphylactic and anaphylactoid reactions to aspirin and nonsteroidal anti-inflammatory drugs. Immunology and Allergy Clinics of North America 21, 745–768.

    Google Scholar 

  3. Czerniawska-Mysik, G., and Szczeklik, A. (1981), Idiosyncrasy to pyrazolone drugs. Allergy 36, 381–384.

    Article  PubMed  CAS  Google Scholar 

  4. Stevenson, D. D. (1995), Aspirin and nonsteroidal antiinflammatory drugs. Immunology and Allergy Clinics of North America 15, 529–549.

    Google Scholar 

  5. Quiralte, J., Blanco, C., Castillo, R., Ortega, N., and Carrillo, T. (1997), Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies. Ann. Allergy Asthma Immunol. 78, 293–296.

    PubMed  CAS  Google Scholar 

  6. Stevenson, D. (1998), Adverse reactions to nonsteroidal antiinflammatory drugs. N. American Clinics Allergy and Immunology 18:4, 773–798.

    Article  Google Scholar 

  7. Settipane, R. A., and Stevenson, D. D. (1989), Cross sensitivity with acetaminophen in aspirin sensitive asthmatics. J. Allergy and Clin. Immunol. 84, 26–33.

    Article  CAS  Google Scholar 

  8. Stevenson, D. D., Hougham, A., Schrank, P., Goldlust, B., and Wilson, R. (1990), Disalcid cross-sensitivity in aspirin sensitive asthmatics. J. Allergy Clin. Immunol. 86, 749–758.

    Article  PubMed  CAS  Google Scholar 

  9. Stevenson, D. D., Simon, R. A., Lumry, W. R., and Mathison, D. A. (1986), Adverse reactions to tartrazine. J. Allergy Clin. Immunol. 78, 182–191.

    Article  PubMed  CAS  Google Scholar 

  10. Stevenson, D. D. and Simon, R. A. Sulfite induced asthma, in Current Therapy in Internal Medicine, Bayless, Brain, and Cherniack, eds., B.C., 1987, pp. 14-10.

  11. Feigenbaum, B. A., Stevenson, D. D., and Simon, R. A. (1995), Lack of cross-sensitivity to IV hydrocortisone in aspirin-sensitive subjects with asthma. J. Allergy Clin. Immunol. 96, 545–548.

    Article  PubMed  CAS  Google Scholar 

  12. Woessner, K., Simon, R. A., and Stevenson, D. D. (1999), Monosodium glutamate sensitivity in asthma. J. Allergy Clin. Immunol. 104, 305–310.

    Article  PubMed  CAS  Google Scholar 

  13. Stevenson, D., and Simon, R. A. (2001), Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients. J. Allergy Clin. Immunol. 108, 47–51.

    Article  PubMed  CAS  Google Scholar 

  14. Woessner, K., Simon, R. A., and Stevenson, D. D. (2002), The safety of celecoxib in aspirin exacer-bated respiratory disease. Arthritis Rheum. 46, 2201–2206.

    Article  PubMed  CAS  Google Scholar 

  15. Sanchez-Borges, M., Capriles-Hulett, A., Caballero-Fonseca, F., and Ramon-Perez, C. (2001), Tolerability to new Cox-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann. Allergy Asthma Immunol. 87, 201–204.

    PubMed  CAS  Google Scholar 

  16. Pacor, M., Di Lorenzo, G., Biasi, D., Barbagallo, M., and Corrocher, R. (2002), Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal antiinflammatory drugs. Clin. Exp. Allergy 32, 397–400.

    Article  PubMed  CAS  Google Scholar 

  17. Quiralte, J. S. dS. P., B., and Florido, J. J. (2002), Safety of selective cyclooxgenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions. Ann. Allergy Asthma Immunol. 89, 63–66.

    PubMed  CAS  Google Scholar 

  18. Berges-Gimeno, M., Camacho-Garrido, E., Garcia-Rodriguez, R. M., Martin-Garcia, C., Alfaya, T., and Hinojosa, M. (2001), Rofecoxib: safe in NSAID intolerant patients. Euro. J. Allergy Clin. Immunol. 56, 1017–1018.

    Article  CAS  Google Scholar 

  19. Berges-Gimeno, M., Simon, R. A., and Stevenson, D. D. (2002), The effect of leukotriene modifier drugs on asa-induced asthma and rhinitis reactions. Clin. Exp. Allergy (Accepted for publication.)

  20. Zeiss, C. R., and Lockey, R. F. (1976), Refractory period to aspirin in a patient with aspirin-induced asthma. J. Allergy Clin. Immunol. 57, 440–448.

    Article  PubMed  CAS  Google Scholar 

  21. Pleskow, W. W., Stevenson, D. D., Mathison, D. A., Simon, R. A., Schatz, M., and Zieger, R. S. (1982), Aspirin desensitization in aspirin sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J. Allergy Clin. Immunol. 69, 11–19.

    Article  PubMed  CAS  Google Scholar 

  22. Widal, M. F., Abrami, P., and Lermeyez, J. (1922), Ana-phylaxie et idiosyncrasie. Presse Med. 30, 189–192.

    CAS  Google Scholar 

  23. Mathison, D. A., Lumry, W. R., and Stevenson, D. D. (1982), Aspirin in chronic urticaria and/or angioedema: studies of sensitivity and desensitization. J. Allergy Clin. Immunol. 69, 135.

    Article  Google Scholar 

  24. Slavin, R. G. (1992), Asthma and sinusitis. J. Allergy Clin. Immunol. 90, 534–537.

    Article  PubMed  CAS  Google Scholar 

  25. Mastalerz, L., Milewski, M., Duplaga, M., Nizankowska, E., and Szczeklik, A. (1997), Intranasal fluti-casone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma. Allergy 52, 895–900.

    Article  PubMed  CAS  Google Scholar 

  26. Berges-Gimeno, M., Simon, R. A., and Stevenson, D. D. (2002), The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann. Allergy Asthma Immunol. (Accepted for publication.)

  27. Mathison, D. A., and Stevenson, D. D. Aspirin sensitivity in rhinosinusitis-asthma, in Current Therapy in Allergy, Immunology and Rheumatology, Lichtenstein, L. M., and Fauci, A. S., eds., vol. 1, 1st ed. Mosby, St. Louis, 1985, pp. 27–30.

    Google Scholar 

  28. McFadden, E. A., Woodson, B. T., Fink, J. N., and Toohill, R. J. (1997), Surgical treatment of aspirin triad sinusitis. Am. J. Rhinol. 11, 263–270.

    PubMed  CAS  Google Scholar 

  29. Nakamura, H., Kawasaki, M., Higuchi, Y., and Takahashi, S. (1999), Effects of sinus surgery on asthma in aspirin triad patients. Acta Otolaryngol. 119, 592–598.

    Article  PubMed  CAS  Google Scholar 

  30. Schaitkin, B., May, M., Shapiro, A., Fucci, M., and Mester, S. J. (1993), Endoscopic sinus surgery: 4-year follow-up on the first 100 patients. Laryngoscope 103, 1117–1120.

    Article  PubMed  CAS  Google Scholar 

  31. Kennedy, D. W. (1992), Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 102, 1–18.

    PubMed  CAS  Google Scholar 

  32. Stevenson, D. D., Hankammer, M. A., Mathison, D. A., Christensen, S. C., and Simon, R. A. (1986), Long term ASA desensitization-treatment of aspirin sensitive asthmatic patients: clinical outcome studies. J. Allergy Clin. Immunol. 98, 751–758.

    Article  Google Scholar 

  33. Dahlen, B. N., Szczeklik, A., Zetterstrom, O., Bochenek, G., Kumlin, M., Mastalerz, L., et al. (1998), Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am. J. Respir. Cril. Care Med. 157, 1187–1194.

    CAS  Google Scholar 

  34. Dahlen, S., Malstrom, K., Nizankowska, E., Dahlen, B., Kuna, P., Kowalski, M. et al. (2002), Improvement of aspirin-intolerant asthma by montelukast, a leukotriene anatagonist. A randomised, double blind, placebo controlled trial. Am. J. Respir. Crit. Care Med. 165, 9–14.

    PubMed  Google Scholar 

  35. Dahlen, B. (2000), Treatment of aspirin-intolerant asthma with antileukotrienes. Am. J. Respir. Crit. Care Med. 161, S137-S141.

    PubMed  CAS  Google Scholar 

  36. Stevenson, D. D., Simon, R. A., and Mathison, D. A. (1980), Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J. Allergy Clin. Immunol. 66, 82–88.

    Article  PubMed  CAS  Google Scholar 

  37. Stevenson, D. D., Pleskow, W. W., Simon, R. A., Mathison, D. A., Lumry, W. R., Schatz, M., et al. (1983), Treatment of aspirin sensitive asthma rhinosinusitis with aspirin. J. Allergy Clin. Immunol. 71(2), 272–270.

    Google Scholar 

  38. Sweet, J. A., Stevenson, D. D., Simon, R. A., and Mathison, D. A. (1990), Long term effects of aspirin desensitization treatment for aspirin sensitive rhinosinusitis asthma. J. Allergy Clin. Immunol. 86, 59–65.

    Article  Google Scholar 

  39. Patriarca, G., Bellioni, P., Nucera, E., Schiavino, D., Papa, G., Schinco, G., et al. (1991), Intranasal treatment with lysine acetylsalcylate in patients with nasal polyposis. Ann. Allergy 67, 588–593.

    PubMed  CAS  Google Scholar 

  40. Widal, M. F., Abrami, P., Lermeyez, J. (1922), Anaphylaxie et idiosyncrasie. Presse Med. 30, 189–192.

    CAS  Google Scholar 

  41. Samter, M., and Beers, R., Jr. (1968), Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann. Intern. Med. 68, 975–983.

    PubMed  CAS  Google Scholar 

  42. Samter, M., and Beers, R. F. (1967), Concerning the nature of the intolerance to aspirin. J. Allergy 40, 281–293.

    Article  PubMed  CAS  Google Scholar 

  43. Szczeklik, A., and Stevenson, D. D. (1999), Aspirin-induced asthma: advances in pathogenesis and management. J. Allergy Clin. Immunol. 104, 5–13.

    Article  PubMed  CAS  Google Scholar 

  44. Spector, S. L., Wangaard, C. H., and Farr, R. S. (1979), Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J. Allergy Clin. Immunol. 64(6 Pt 1), 500–506.

    Article  PubMed  CAS  Google Scholar 

  45. McDonald, J., Mathison, D. A., and Stevenson, D. D. (1972), Aspirin intolerance in asthma—detection by challenge. J. Allergy Clin. Immunol. 50, 198–207.

    Article  PubMed  CAS  Google Scholar 

  46. Weber, R. W., Hoffman, M., Raine, D. A., and Nelson, H. S. (1979), Incidence of bron-choconstriction due to aspirin, azo dyes, nonazo dyes, and preservatives in a population of perennial asthmatics. J. Allergy Clin. Immunol. 64, 32–37.

    Article  PubMed  CAS  Google Scholar 

  47. Falliers, C. J. (1973), Aspirin and subtypes of asthma: risk factor analysis. J. Allergy Clin. Immunol. 52, 141–147.

    Article  PubMed  CAS  Google Scholar 

  48. Raika, G., and Skog, E. (1965), On the relationship between drug allergy and atopy. Acta Allergol. 20, 387.

    Google Scholar 

  49. Schuhl, J. F., and Pereyra, J. G. (1979), Oral acety-salicylic acid (aspirin) challenge in asthmatic children. Clin. Allergy 9, 83–88.

    Article  PubMed  CAS  Google Scholar 

  50. Towns, S. J., and Mellis, C. M. (1984), Role of acetyl salicylic acid and sodium metabisulfite in chronic childhood asthma. Pediatrics 73, 631–637.

    PubMed  CAS  Google Scholar 

  51. Vedanthan, P. K., Menon, M. M., Bell, T. D., and Bergin, D. (1977), Aspirin and tartrazine oral chal-lenge: incidence of adverse response in chronic childhood asthma. J. Allergy Clin. Immunol. 60, 8–13.

    Article  PubMed  CAS  Google Scholar 

  52. Rachelefsky, G. S., Coulson, A., Siegel, S. C., and Stiehm, E. R. (1975), Aspirin intolerance in chronic chilhood asthma: detection by oral challenge. Pediatrics 56, 443–448.

    PubMed  CAS  Google Scholar 

  53. Szczeklik, A. and Sanak, M. (2000), Genetic mechanisms in aspirin-induced asthma. Am. J. Respir. Crit. Care Med. 161, S142-S146.

    PubMed  CAS  Google Scholar 

  54. Stevenson, D. (1998), Adverse reactions to nonsteroidal anti-inflammatory drugs. N. American Clinics Allergy and Immunology 18:4, 773–798.

    Article  Google Scholar 

  55. Stevenson, D., and Simon, R. A. (2001), Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients. J. Allergy Clin. Immunol. 108, 47–51.

    Article  PubMed  CAS  Google Scholar 

  56. Picado, C., Castillo, J. A., Montserrat, J. M., and Agusti-Vidal, A. (1989), Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur. Respir. 2, 127–129.

    CAS  Google Scholar 

  57. Marquette, C., Saulnier, F., Leroy, O., Wallaert, B., Chopin, C., Demarcq, J. M., et al. (1992), Long-term prognosis for near-fatal asthma: a 6-year follow up study of 145 asthmatic patients who underwent mechanical ventilation for near fatal asthma. Am. Rev. Resp. Dis. 146, 76–81.

    PubMed  CAS  Google Scholar 

  58. Stevenson, D. and Simon, R. A.. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs in Allergy: Principles and Practice, Middleton, Jr., E., Ellis, E. F., Yunginger, J. W., Reed, C. E., Adkinson, Jr. N. F., and Busse, W. W., eds., vol. 2, 5th ed., Mosby, St. Louis, 1998, pp. 1225–1234.

    Google Scholar 

  59. Pleskow, W. W., Stevenson, D. D., Mathison, D. A., Simon, R. A., Schatz, M., and Zieger, R. S. (1983), Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin. J. Allergy Clin. Immunol. 71, 574–579.

    Article  PubMed  CAS  Google Scholar 

  60. Bosso, J. V., Schwartz, L. B., and Stevenson, D. D. (1991), Tryptase and histamine release during aspirin-induced respiratory reactions. J. Allergy Clin. Immunol. 88, 830–837.

    Article  PubMed  CAS  Google Scholar 

  61. Berges-Gimeno, M., Simon, R. A., and Stevenson, D. D. (2002), The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann. Allergy Asthma Immunol. (Accepted for publication).

  62. Nizankowska, E. and Szczeklik, A. (1989), Glucocorticosteroids attenuate aspirin-precipitated adverse reactions in aspirin-intolerant patients with asthma. Ann. Allergy 63, 159–162.

    PubMed  CAS  Google Scholar 

  63. Stevenson, D., Simon, R. A., Mathison, D. A., and Christiansen, S. C. (2000), Montelukast is only partially effective in inhibiting aspirin responses in aspirin sensitive asthmatics. Ann. Allergy Asthma Immunol. 85, 477–482.

    PubMed  CAS  Google Scholar 

  64. Nizankowska, E., Dworski, R., Soja, J., and Szczeklik, A. (1990), Salicylate pre-treatment attenuates intensity of bronchial and nasal symptoms precipitated by aspirin in aspirin-intolerant patients. Clin. Exp. Allergy 20, 647–652.

    Article  PubMed  CAS  Google Scholar 

  65. Nizankowska, E., Bestynska-Krypel, A., Cmiel, A., and Szczeklik, A. (2000), Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur. Respir. J. 15, 863–869.

    Article  PubMed  CAS  Google Scholar 

  66. Patriarca, G., Nucera, E., and Di Rienzo, V. (1991), Nasal provocation test with lysine acetylsalicylate (LAS) in aspirin-sensitive patients. Ann. Allergy 67, 60–62.

    PubMed  CAS  Google Scholar 

  67. Pawlowicz, A., Williams, W. R., and Davies, B. H. (1991), Inhalation and nasal challenge in the diagnosis of aspirin induced asthma. Allergy 46, 405–409.

    PubMed  CAS  Google Scholar 

  68. Schapowal, A., S.-S. M., Szczeklik, A., Bruijnzeel, P., Hansel, T., and Virchovsen, Chr. (1990), Lysineaspirin nasal provocation and anterior rhinomanometry for the diagnosis of aspirinsensitive asthma. Atemwegs. Lungenkrankh 16, S1-S5.

    Google Scholar 

  69. Wellbrock, M. M. J., Cornelius, M., and Brasch, J. (1993), Intranasal provocation with lysine acetylsalicylic acid. HNO 41, 577–581.

    PubMed  CAS  Google Scholar 

  70. Milewski, M., Mastalerz, L., Nizankowska, E., and Szczeklik, A. (1998), Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J. Allergy Clin. Immunol. 101, 581–586.

    Article  PubMed  CAS  Google Scholar 

  71. Szczeklik, A. and Serwonska, M. (1979), Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clematine. Thorax 34, 654–658.

    PubMed  CAS  Google Scholar 

  72. Szczeklik, A., Mastalerz, L., Nizankowska, E., and Cmiel, A. (1996), Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am. J. Respir. Crit. Care Med. 153, 567–571.

    PubMed  CAS  Google Scholar 

  73. Szczeklik, A., Dworski, R., Mastalerz, L., Prokop, A., Sheller, J., Nizankowska, E., et al. (1998), Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism. Am. J. Respir. Crit. Care Med. 158, 1168–1172.

    PubMed  CAS  Google Scholar 

  74. Martelli, N. A. U. G. (1977), Inhibition of aspirin-induced bronchoconstriction by sodium cromoglycate inhalation. Thorax 32, 684.

    Article  PubMed  CAS  Google Scholar 

  75. Basomba, A. R. A., Pelaez, A., Villalmanzo, I. G., and Campos, A. (1976), The effect of sodium cromoglycate in preventing aspirin induced bronchospasm. Clin. Allergy 6, 269.

    Article  PubMed  CAS  Google Scholar 

  76. Stevenson, D. D., Simon, R. A., and Mathison, D. A., (1984), Cromolyn pretreatment delays onset of aspirin (ASA) induced asthmatic reactions. J. Allergy Clin. Immunol. 73, 162.

    Article  Google Scholar 

  77. Pauls, J. D., Simon, R. A., Daffern, P. J., Stevenson, D. D. (2000), Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics. Ann. Allergy Asthma Immunol. 85, 40–45.

    Article  PubMed  CAS  Google Scholar 

  78. Berges-Gimeno, M., Simon, R. A., and Stevenson, D. D. (2002), The effect of leukotriene modifier drugs on ASA-induced asthma and rhinitis reactions. Clin. Exp. Allergy (Accepted for publication.)

  79. Szczeklik, A., Nizankowska, E., and Duplaga, M. (2000), Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur. Respir. J. 16, 432–436.

    Article  PubMed  CAS  Google Scholar 

  80. Vento, S. I., Ertama, L. O., Hytonen, M. L., Wolff, C. H. J., Malmberg, C. H. J. (2000), Nasal polyps: clinical course during 20 years. Ann. Allergy Asthma Immunol. 85, 209–214.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 37205, Nashville, TN

    John M. Fahrenholz (Allergy and Asthma Specialists)

Authors
  1. John M. Fahrenholz
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Formerly Scripps Clinic and Green Hospital, La Jolla, CA

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fahrenholz, J.M. Natural history and clinical features of aspirin-exacerbated respiratory disease. Clinic Rev Allerg Immunol 24, 113–124 (2003). https://doi.org/10.1385/CRIAI:24:2:113

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/CRIAI:24:2:113

Index Entries

Search

Navigation